Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpe Special Opp Regulatory News (ESO)

Share Price Information for Epe Special Opp (ESO)

Share Price is delayed by 15 minutes
Get Live Data
235.00    -1.00 (-0.42%)
Bid:
230.00
Ask:
240.00
Spread: 10.00 (4.348%)
Market Cap: £57.44m
ESO Live PriceLast checked at - London Stock Exchange

Intraday Epe Special Opp Share Chart

Investment

2 Sep 2020 07:00

RNS Number : 7437X
EPE Special Opportunities Limited
02 September 2020
 

EPE Special Opportunities Limited

 

Investment

 

 

EPE Special Opportunities Limited ("ESO" or the "Company") is pleased to announce that on 1 September 2020 it completed a £1.9 million investment in Atlantic Credit Opportunities Fund ("ACOF"), satisfied by cash payment.

 

ACOF is a commingled distressed credit fund targeting a gross annual return of 10-12%. The Company's investment in ACOF will provide ESO with the opportunity to generate uncorrelated returns through exposure to the significant dislocations in credit markets caused by the COVID-19 pandemic. ACOF will also continue to invest in idiosyncratic situations which have nothing to do with the pandemic.

 

EPIC Private Equity LLP ("EPE"), the investment advisor to the Company and a related party, has undertaken, subject to regulatory approval, to acquire a controlling interest in Atlantic Capital Management Limited ("ACML"), the investment manager of ACOF.

 

The Company will hold its investment in ACOF through ESO Alternative Investments LP ("ESO AI LP"). ESO will not pay any management or performance fees to ACML.

 

ESO is the sole investor in ESO AI LP, a vehicle which holds the Company's primary and secondary fund investments. ESO AI LP's acquisition will diversify the Company's asset class exposure, in line with the Company's stated investment strategy.

 

The person responsible for releasing this information on behalf of the Company is Amanda Robinson of Langham Hall Fund Management (Jersey) Limited.

 

Enquiries:

 

EPIC Private Equity LLP

+44 (0) 207 269 8865

Alex Leslie

Langham Hall Fund Management (Jersey) Limited

+44 (0) 153 488 5200

Amanda Robinson

Cardew Group Limited

+44 (0) 207 930 0777

Richard Spiegelberg

Numis Securities Limited

+44 (0) 207 260 1000

Nominated Advisor:

Stuart Skinner

Corporate Broker:

Charles Farquhar

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQLBMBTMTTMTPM
Date   Source Headline
17th Oct 20257:00 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSHolding(s) in Company
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 202510:15 amRNSAnnouncement of Ordinary and ZDP Share Buybacks
23rd Sep 20257:00 amRNSNet Asset Value(s)
9th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSPortfolio Update
8th Aug 20254:00 pmRNSUpdate on Share Buy Backs
25th Jul 20255:00 pmRNSHolding(s) in Company
24th Jul 20256:00 pmRNSInterest Payment on Unsecured Loan Notes
14th Jul 20251:00 pmRNSNet Asset Value(s)
10th Jul 20257:15 amRNSHolding(s) in Company
10th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 202510:00 amRNSInvestment
30th Jun 20257:00 amRNSChange of Nominated Adviser
27th Jun 20258:00 amRNSResults of Annual General Meeting
26th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:30 amRNSTransaction in Own Shares
17th Jun 20251:00 pmRNSNet Asset Value(s)
13th Jun 20251:00 pmRNSProposed Extension of Unsecured Loan Notes
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 202511:57 amRNSTransaction in Own Shares
29th May 20255:30 pmRNSTransaction in Own Shares
28th May 20257:15 amRNSHolding(s) in Company
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20255:30 pmRNSNotice of Annual General Meeting
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20253:00 pmRNSNet Asset Value(s)
15th May 20257:15 amRNSHolding(s) in Company
15th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:15 amRNSAnnual Financial Report
2nd May 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSNet Asset Value(s)
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:20 amRNSTransaction in Own Shares
14th Apr 20257:10 amRNSVesting - Share Matching Scheme/PDMR Shareholdings
14th Apr 20257:00 amRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20251:00 pmRNSAnnouncement of Share Buy Backs
26th Mar 20257:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.